CPHS/OPHS Glossary of Terms
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Adverse Event:
Any untoward or unfavorable medical occurrence in a human subject,
including any abnormal sign (for example, abnormal physical exam
or laboratory finding), symptom, or disease, temporally associated
with the subject’s participation in the research, whether or
not considered related to the subject’s participation in the
research. Adverse events may also be psychological in nature. (See
also: Serious Adverse Event and
Unexpected Adverse Event).
Amendment:
Modification or change to a currently approved study (protocol or
consent materials). All amendments require IRB review and approval prior to implementation (unless correcting
only grammatical or typographical errors). (See also: Approval, Continuing Review, Minor Amendment and Expiration Date)
Anonymous:
Anonymous data collection means that no identifiable information
(e.g. name, address, student ID number, email address, phone number)
is connected to the data either directly or through a coding system
at any point in the study. In addition to videotapes and photographs,
audio recordings are not considered to be anonymous. It is also possible
that multiple pieces of information, none of which are identifiable
on their own, may uniquely identify a person when brought together;
in this case, the data would not be considered anonymous.
Approval:
The determination of the IRB that the research satisfies the applicable University, State and
Federal requirements for research involving human subjects and has
permission to proceed. The approval period can vary and is described
under Continuing Review. (See also: Amendment, Continuing Review and Expiration Date)
Assent:
The agreement to participate in a research study given by a child
or an adult who lacks full decision-making capacity or authority
to give legally valid informed consent. In the absence of affirmative
agreement, failure to object should not be construed as assent.
Assurance:
A formal written, binding commitment that is submitted to a federal
agency in which an institution promises to comply with applicable
regulations governing research with human subjects and use of animals
and stipulates the procedures through which compliance will be achieved.
Authorization:
Under HIPAA, the granting of rights to
access protected health information (PHI). Required by HIPAA for disclosures or uses other than for
treatment, payment or operations (which are covered in the Notice
of Privacy Practices). Treatment cannot be conditioned on granting
of an authorization. An authorization is a specific, detailed document
as to the PHI covered and its uses.
Authorized Institutional Official:
An officer of an institution with the authority to speak for and
legally commit the institution to adherence to the requirements of
the federal regulations regarding the involvement of human subjects
in biomedical and behavioral research.
Autonomy:
Personal capacities to consider alternatives, make choices, and act
without undue influence or interference of others.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Belmont Report:
A statement of basic ethical principles governing research involving
human subjects issued by the National Commission for the Protection
of Human Subjects in 1978.
Beneficence:
An ethical principle discussed in the Belmont Report that entails
an obligation to protect persons from harm. The principle of beneficence
can be expressed in two general rules: (l) do not harm; and (2) protect
from harm by maximizing possible benefits and minimizing possible
risks of harm.
Benefit:
A valued or desired outcome; an advantage. Note:
Compensation or payment for participation in research is
not considered to be a benefit of the research.
Berkeley Stem Cell Center:
A multi-disciplinary group of scientists, physicians, and humanities
and legal scholars at UC Berkeley committed to the study of new technologies
of human stem cell research.
Biosafety Officer:
The Biosafety Officer provides compliance assistance, technical information,
and training to assist UC Berkeley faculty and staff in meeting the
requirements of local, State and Federal regulations and established
policies for the possession, use or transport of biohazards and potentially
biohazardous materials. For more information, visit Biosafety on the EH&S website.
BUA
:
Biological Use Authorization - An authorization/approval number issued for research involving
biological use(s) from the Biosafety Office at UC Berkeley. See also:
Biosafety Officer.
A | B | C | D | E | F| G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
California Public Records Act:
Modeled after the Freedom of Information Act, the public may request
to inspect the public records of California state and local agencies
during business hours. There are nine exceptions and four exclusions
to this statue. Also known as CPRA or California Freedom of Information
Act.
CDC:
Centers for Disease Control and Prevention - An agency within the Department of Health and Human Services,
the Centers for Disease Control and Prevention (CDC) is recognized
as the lead federal agency for protecting the health and safety of
people - at home and abroad, providing credible information to enhance
health decisions, and promoting health through strong partnerships.
Certificate of Confidentiality:
An advance grant of confidentiality issued to a research study by
the Department of Health and Human Services, National Institutes
of Health in certain circumstances or the Federal Drug Administration
(FDA) for FDA-regulated research; It is intended to provide protection
against forced disclosure, even against a subpoena, of individually
identifiable research data. (This procedure has received little legal
testing and it is not known if a Certificate of Confidentiality (CoC)
would hold up if challenged.) Visit
Certificates of Confidentiality for more information.
Certification:
The official notification by the institution to the supporting Department
or Agency that a research project or activity involving human subjects
has been reviewed and approved by an IRB in accordance with an approved assurance. If required, it includes
documentation to funding agencies that a PI has completed specific
training in the ethical conduct of human subjects research.
CFR
:
Code of Federal Regulations - The Code of Federal Regulations (CFR) is a codification of the
general and permanent rules published in the Federal Register by
the Executive departments and agencies of the Federal Government.
It details the laws that govern research with human participants.
Children:
Persons who have not attained the legal age for consent to treatments
or procedures involved in the research, under the applicable law
of the jurisdiction in which the research will be conducted. In California,
the legal age for such consent is usually 18 years old, but some
exceptions apply under state law. California law or applicable laws
of other states or countries where the research is being conducted
will be considered by CPHS.
CITI
:
Collaborative Institutional Training Initiative
-An online modular training program on
research compliance topics. The human research protection
training that is required for UCB faculty (with some exceptions), post docs, research staff, students (graduate/undergraduate)
and volunteer research staff engaging in research.
Class I, II, III Devices:
Classification by the Food and Drug Administration of medical devices
according to potential risks or hazards. Class I devices are deemed
to be low risk and are therefore subject to the least regulatory
controls. Class III devices are generally the highest risk devices
and are therefore subject to the highest level of regulatory control.
Classified Research:
Research, either whole projects or portions thereof, that has a security
classification established by a federal agency, OR
industrially sponsored proprietary research for which the
sponsor requires a delay in publication in excess of six months.
Clinical Investigation:
Considered by the FDA to be any experiment that involves a test article and one or more human subjects, and that either: a)
must meet the requirements for prior submission to the Food and
Drug Administration; or b) the results of which are intended to
be later submitted to, or held for inspection by, the FDA as
part of an application for a research or marketing permit. The
terms research, clinical research, clinical study, study, and
clinical investigation are deemed to be synonymous. Note: The DHHS regulatory definition
of research is different.
Clinical Laboratory Improvements Amendments:
The Clinical Laboratory Improvement Amendments (CLIA) was passed
by Congress in 1988. CLIA established quality standards for all laboratory
tests to ensure the accuracy, reliability, and timeliness of patient
test results, regardless of where the test was performed. CLIA defines
a clinical laboratory as any facility which performs testing on specimens
derived from humans for the purpose of providing data for the diagnosis,
prevention, or treatment of disease in an individual, or for the
purpose of health assessment. CLIA states that laboratories that
perform tests on human specimens and report patient-specific results
must be certified under the CLIA provisions. Researchers should use
CLIA-certified laboratories when the results will be shared with
subjects, or their physicians. Conversely, if researchers do not
plan to share results with subjects, or their physicians, testing
could be performed via any appropriate laboratory. For more information,
refer to the CLIA Guidance.
Clinical Trial:
An “applicable” clinical trial defined by the Food and
Drug Administration is a trial that must be posted on clinicaltrials.gov. There are two main types of clinical trials:
(1) Controlled, clinical investigations of a drug or biologic subject
to FDA regulation; or
(2) Controlled trials of devices with health outcomes and pediatric
post-market surveillance.
Cloud Computing:
Off-site, distant storage or data management servers typically owned
and operated by a third party.
CoC: See: Certificate of Confidentiality.
Coercion:
An overt or implicit threat of harm/negative consequences or reprisal
is intentionally presented by one person to another in order to obtain
compliance.
Cognitively Impaired Persons:
Individuals who have either a psychiatric disorder (e.g., psychosis,
neurosis, personality or behavior disorders) an organic impairment
(e.g., dementia) or a developmental disorder (e.g.,
mental retardation) that affects cognitive or emotional
functions to the extent that capacity for judgment and reasoning
is significantly diminished. This includes persons under the
influence of or dependent on drugs or alcohol, those suffering
from degenerative diseases affecting the brain, terminally ill
patients, and persons with severely disabling physical
handicaps, may also be compromised in their ability to make
decisions in their best interests.
Coded Data Set:
Data that has been stripped of identifiers (such as name or social
security number) and assigned an identity code (typically a randomly
generated number) which is associated with and unique to each specific
individual; and a key to decipher the code exists, enabling linkage
of the data to personal identifiers. This identity code should not
offer any clue as to the identity of an individual.
COIC:
See: Conflict of Interest Committee.
Competence:
A legal term used to denote capacity to act on one's own behalf;
the ability to understand information presented, to appreciate the
consequences of acting (or not acting) on that information, and to
make a choice. (See also: Incompetence, Incapacity)
Confidential Resource:
A confidential resource includes the following employees who receive
reports in their confidential capacity:
CARE Advocates, Ombuds, Licensed counselors in student counseling centers and in employee assistance programs, any persons with a professional license requiring confidentiality (including health center employees but excluding campus legal counsel), or someone who is supervised by such a person.
Designation as a “Confidential Resource” only exempts a person from reporting to the Title IX Officer but not from other mandatory reporting obligations under UC CANRA (Child Abuse and Neglect Reporting Act) Policy, CSA (Clery Act as a Campus Security Authority), and other policies or laws that require reporting to campus or local law enforcement, or Child Protective Services.
Confidentiality:
Pertains to the treatment of information that an individual has disclosed
in a relationship of trust and with the expectation that it will
not be divulged to others without permission in ways that are inconsistent
with the understanding of the original disclosure.
Conflict of Interest Committee:
A faculty committee that reports to the Vice Chancellor for Research
and is responsible for the review, assessment, approval, and management
of all financial disclosures related to research projects at UC Berkeley.
For more information, visit the Conflict of Interest (COI) Committee. website
Consent:
See: Informed Consent.
Continuing Noncompliance:
A pattern of noncompliance that indicates an inability or unwillingness
to comply with the requirements of an applicable law, regulation,
or institutional policy pertaining to the protection of human subjects
and/or with the requirements or determinations of an IRB.
Continuation Review:
See: Continuing Review.
Continuing Review:
The IRB review that must
occur at least once every 12 months for all active, federally-regulated
(FDA or DHHS) protocols, or every 10 years for all active, minimal
risk, non-federally-regulated, non-FDA-regulated, non-Veterans Affairs
protocols without financial conflicts of interest or NIH Certificates
of Confidentiality, after the initial review and approval. Also referred
to as renewal or continuation review. (See also: Amendment, Approval, and Expiration Date).
Covered Entity:
A health plan, a health care clearinghouse, or a health care provider
who electronically transmits health information in connection with
a transaction for which the U.S. Department of Health and Human Services
(HHS) has adopted a standard (e.g., transactions concerning billing
and payment for services or insurance coverage). A covered entity
can be an institution, organization or an individual. These organizations
are subject to regulation by the Health Insurance Portability and
Accountability Act (HIPAA).
CPHS: Committee for Protection of Human Subjects -the Institutional Review Board(s) (IRB) for the University of California at Berkeley.
CPRA: See: California Public Records Act.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Dead Fetus:
An expelled or delivered fetus that exhibits no heartbeat, spontaneous
respiratory activity, spontaneous movement of voluntary muscles,
or pulsation of the umbilical cord (if still attached).
Deception:
When an investigator gives false information to subjects or intentionally
misleads them about some key aspect of the research. (This is sometimes
referred to as "active deception.")
Declaration of Helsinki:
A code of ethics for clinical research approved by the World Medical
Association in 1964 and widely adopted by medical associations in
various countries. It was revised in 1975 and 1989.
De-identified Data (general):
Data that has been stripped of all elements (including but not limited
to personal identifiers and codes with subsequent code key) that
might enable a reasonably informed and determined person to deduce
the identity of the subject.
De-identified Data (under HIPAA):
A record in which identifying information has been removed to render
the health information not subject to the HIPAA rules.
Information has been de-identified using either of the following methods: 1. by removing all 18 elements that could be used to identify the individual or the individual's relatives, employers, or household members (see list of Personal Identifiers under HIPAA) or 2. by using statistical methods to establish de-identification.
The covered entity may assign a code or other means of record identification to allow de-identified information to be re-identified if needed; however, the code must not be derived from, or related to, the removed identifiers and only the covered entity can have the re-linking information.
Device (Medical):
See: Medical Device.
DHHS:
Department of Health and Human Services - (formerly known as DHEW - Department of Health, Education and
Welfare (DHEW)). One of the cabinet-level departments of the US federal
government and the United States government's principal agency for
protecting the health of all Americans and providing essential human
services. The department includes more than 300 programs, covering
a wide spectrum of activities; some of these include the National
Institutes of Health (NIH), the Food and Drug Administration (FDA),
the Centers for Disease Control and Prevention (CDC), and the Office
for Human Research Protections (OHRP).
Disadvantaged Persons:
Individuals lacking the normal or usual necessities and comforts
of life, such as proper housing, educational opportunities, adequate
medical care etc.
DOD
:
Department of Defense (includes Air Force, Army, Advanced Research
Projects Agency, and Navy)- The mission of the Department of Defense is to provide the
military forces needed to deter war and to protect the security
of our country. The department's headquarters are at the
Pentagon.
DOE
:
Department of Energy - The Department of Energy’s
mission is to advance energy technology and
promote related innovation in the United States.
DoED:
Department of Education - The U.S. Department of Education's
mission is to: Strengthen the Federal commitment to assuring access
to equal educational opportunity for every individual; Supplement
and complement the efforts of states, the local school systems and
other instrumentalities of the states, the private sector, public
and private nonprofit educational research institutions, community-based
organizations, parents, and students to improve the quality of education;
Encourage the increased involvement of the public, parents, and students
in Federal education programs; Promote improvements in the quality
and usefulness of education through Federally supported research,
evaluation, and sharing of information; Increase the accountability
of Federal education programs to the President, the Congress, and
the public.
DOT
:
Department of Transportation - The mission of DOT is to serve the United States by ensuring
a fast, safe, efficient, accessible and convenient transportation
system that meets our vital national interests and enhances the quality
of life of the American people, today and into the future.
Drug:
- A substance recognized by an official pharmacopoeia or formulary;
- A substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease;
- A substance (other than food) intended to affect the structure or any function of the body; or
- A substance intended for use as a component of a medicine but not a device or a component, part, or accessory of a device.
- Note: Biological products (e.g., vaccine, virus, or blood) are included within this definition and are generally covered by the same laws and regulations, but differences exist regarding their manufacturing processes (chemical process versus biological process.)
DSMB:
Data and Safety Monitoring Board/Committee (DSMB or DSMC) - An appointed independent group consisting of at least three (3)
members assigned to conduct interim monitoring of accumulating data
from research activities to assure the continuing safety of research
participants, relevance of the study question, appropriateness of
the study, and integrity of the accumulating data. Membership should
include expertise in the relevant field of study, statistics, and
research study design.
DSMP:
Data and Safety Monitoring Plan - A plan to oversee the
implementation of a study protocol for subjects' safety and compliance
monitoring.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Economically Disadvantaged Persons:
See: Disadvantaged Persons.
Educationally Disadvantaged Persons:
See: Disadvantaged Persons.
EH&S:
See: Environment, Health and Safety.
Emancipated Minor:
A legal status conferred upon persons who have not yet attained the
age of legal competency as defined by state law (for such purposes
as consenting to medical care), but who are entitled to treatment
as if they had by virtue of assuming adult responsibilities such
as being self-supporting and not living at home, marriage, or procreation.
(See also: Mature Minor)
Encryption:
Refers to the algorithmic transformation of a data set to an unrecognizable
form from which the original data set or any part thereof can be
recovered only with knowledge of a secret decryption key of suitable
length, and using a suitable algorithm.
Engaged (in human subjects research):
In general, an institution is considered engaged in a particular
non-exempt human subjects research project when its employees or
agents for the purposes of the research project obtain: (1) data
about the subjects of the research through intervention or interaction
with them; (2) identifiable private information about the subjects
of the research; or (3) the informed consent of human subjects for
the research. For more information, see the Office for Human Research
Protections (OHRP) Guidance on Engagement of Institutions in Human Subjects
Research.
Environment, Health and Safety:
UC Berkeley office responsible for providing a safe and healthy environment
for faculty, staff, students, and visitors. The mission of the Office
of Environment, Health and Safety (EH&S) is to prevent or to
minimize injuries and illnesses through the recognition, evaluation,
and control of potential hazards arising from University activities.
For more information, see the EH&S website.
Equitable:
Fair or just; used in the context of selection of subjects to indicate
that the benefits and burdens of research are fairly distributed.
Ethics Advisory Board:
An interdisciplinary group that advises the Secretary, HHS, on general
policy matters and on research proposals (or classes of proposals)
that pose ethical problems.
Exempt Review:
Review of human subjects research that involves almost no risk to
human subjects. There are six (6) federally-defined exempt categories.
UCB requires review by a member of OPHS staff,
an IRB Chair or a designated
voting member to determine whether the research qualifies as exempt
under one or more of the exempt categories.
Expedited Review:
Review of proposed research by the IRB chair or a designated voting member or group of voting members
rather than by the entire IRB. Federal rules permit expedited review
for specific categories of research listed in the regulations at
Federal Register Volume 63, No 216 involving no more than minimal
risk and for minor changes in approved research.
Experimental:
Term often used to denote a therapy (drug, device, procedure) that
is unproven or not yet scientifically validated with respect to safety
and efficacy. A procedure may be considered “experimental”
without necessarily being part of a formal study (research) to evaluate
its usefulness. (See also: Research)
Experimental Study:
A true experimental study is one in which subjects are randomly assigned
to groups that experience carefully controlled interventions manipulated
by the experimenter according to a strict logic allowing causal inference
about the effects of the interventions under investigation.
Experimental Subject’s Bill of Rights:
A list of the rights described in California Health & Safety
Code, Sections 24172 and 24173, that must be offered to all subjects
of medical experimentation. This list of rights must be written in
a language in which the subject is fluent. (See also: Medical Experimentation)
Expiration Date:
The date signifying the end of the period for which CPHS has approved the research. (See also: Amendment, Approval, and Continuing Review)
External Adverse Event:
From the perspective of a UCB Investigator engaged in a multicenter
clinical trial, external adverse events are those adverse events
experienced by subjects enrolled by investigators at other institutions
engaged in the clinical trial (not under UCB IRB authority).
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Faculty Advisor:
See: Faculty Sponsor.
Faculty Sponsor:
A faculty member who has Principal Investigator or Exceptional PI
status per University policy and agrees to sponsor the research of
a student or postdoctoral investigator. The Faculty Sponsor/
Faculty Advisor is responsible for overseeing the protection of the
rights and welfare of the human subjects and adherence to CPHS requirements
as well as applicable federal regulations and state statutes.
FDA:
Food and Drug Administration - Established by Congress in
1912 and presently part of the Department of Health and Human Services,
the FDA oversees safety of foods, drugs, devices, biologics and cosmetics
for human use.
FDA Advisory Councils:
Groups of experts which provide advice and recommendations to the
FDA.
Federal Policy (The):
The federal policy that provides regulations for the involvement
of human subjects in research. The Policy applies to all research
involving human subjects conducted, supported, or otherwise subject
to regulation by any federal department or agency that takes appropriate
administrative action to make the Policy applicable to such research.
Currently, seventeen federal agencies have adopted the Federal Policy.
Also referred to as the “Common Rule.”
Federalwide Assurance:
The Federal Policy for the Protection of Human Subjects requires
that each institution “engaged” in Federally-supported
non-exempt human subject research file in “Assurance”
of protection for human subjects. The Assurance formalizes the institution’s
commitment to protect human subjects. The requirement to file an
Assurance includes both “awardee” and collaborating “performance
site” institutions. Per Federal Policy, awardees and their
collaborating institutions become “engaged” in human
subject research whenever their employees or agents (i) intervene
or interact with living individuals for research purposes; or (ii)
obtain, release, or access individually identifiable private information
for research purposes.
Fetal Material:
The placenta, amniotic fluid, fetal membranes, and umbilical cord.
Fetus:
The product of conception from the time of implantation until delivery.
If the delivered or expelled fetus is viable, it is designated an
infant. The term “fetus” generally refers to later phases
of development; the term “embryo” is usually used for
earlier phases of development.
FIC
:
Fogarty International Center (NIH) - The Fogarty International
Center promotes and supports scientific research and training internationally
to reduce disparities in global health.
FOIA:
Freedom of Information Act - Federal law which requires
federal agencies to disclose records when requests are made in writing.
There are nine exemptions and three exclusions to this statute.
Full Board Review:
See: Full Committee Review.
Full Committee Review:
Review of proposed research at a convened meeting at which a majority
of the IRB members are present,
including at least one member whose primary concerns are in nonscientific
areas. For the review of FDA-regulated research, there shall be at
least one member who is a physician. For the research to be approved,
it must receive the approval of a majority of those members present
at the meeting.
FWA:
See: Federalwide Assurance.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Guardian:
An individual who is authorized under applicable state or local law
to give permission on behalf of a child to general medical care.
Health information and Individually identifiable health
information:
Health information means any information, whether oral or recorded
in any form or medium, that is created or received by a health care
provider, health plan, public health authority, employer, life insurer,
school or university, or health care clearinghouse; and relates to
the past, present, or future physical or mental health or condition
of any individual, the provision of health care to an individual,
or the past, present, or future payment for the provision of health
care to an individual.
Individually identifiable health information is information that is a subset of health information, including demographic information collected from an individual, and is created or received by a health care provider, health plan, employer, or health care clearinghouse; and relates to the past, present, or future physical or mental health or condition of an individual; the provision of health care to an individual; or the past, present, or future payment for the provision of health care to an individual; and that identifies the individual; or with respect to which there is a reasonable basis to believe the information can be used to identify the individual.
Helsinki Declaration:
See: Declaration of Helsinki.
HIPAA:
The Health Insurance Portability and Accountability Act (HIPAA) regulates
the protection of private health information for individuals. HIPAA’s
”Privacy Rule” sets standards for the use and disclosure
of Protected Health Information (PHI) obtained from a covered entity (refer to: Covered Entity). For more information, see CPHS’ HIPAA Guidelines.
HRPP:
See: Human Research Protection Program.
Human Research Data Set:
A body of informational elements, facts, and statistics about a living
individual obtained for research purposes. This includes information
collected by an investigator through intervention/interaction with
the individual or identifiable private information obtained without
intervention/interaction with the individual.
Human Research Protection Program:
The systematic and comprehensive approach by an organization to the
protection of human subjects in research.
Human Subject:
A living individual about whom an investigator conducting research:
(1) obtains information or biospecimens through intervention or interaction
with the individual and uses, studies, or analyzes the information
or biospecimens; or (2) obtains, uses, studies, analyzes, or generates
identifiable private information or identifiable biospecimens. Sometimes
also referred to as Participant. (See also: Research)
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
IDE:
Investigational Device Exemption- IDE refers to the
regulations under 21 CFR 812. An approved IDE means that the IRB (and FDA for significant risk devices) has approved the sponsor’s study application and all
the requirements under 21 CFR 812 are met.
Identifiable Information:
Information that can be linked to specific individuals either directly
or indirectly through coding systems, or when characteristics of
the information are such that by their nature a reasonably knowledgeable
and determined person could ascertain the identities of individuals.
Identity-Only Data Set:
Set of data that contains any and all personal identifiers absolutely
necessary for future conduct of the research and the key to the identity
code that can be used to link or merge personal identifiers with
the coded set.
Incapacity:
Refers to a person's mental status and means inability to understand
information presented, to appreciate the consequences of acting (or
not acting) on that information, and to make a choice. Often used
as a synonym for incompetence. (See also: Incompetence)
Incompetence:
Technically, a legal term meaning inability to manage one's own affairs.
Often used as a synonym for incapacity. (See also: Incapacity)
IND:
Investigational New Drug Application
-
An Investigational New Drug Application (IND) is a
request for authorization from the Food and Drug Administration
(FDA) to administer an investigational drug or biological
product to humans. Such authorization must be secured prior to
interstate shipment and administration of any new drug or
biological product that is not the subject of an approved New
Drug Application or Biologics/Product License Application.
Individual Investigator Agreement:
An agreement that permits an individual collaborator who is not affiliated
with an institution with its own IRB or ethics review board to rely on UC Berkeley’s IRB review.
Also referred to as an IIA.
Informed Consent:
A person's voluntary agreement, based upon adequate knowledge and
understanding of relevant information, to participate in research
or to undergo a diagnostic, therapeutic, or preventive procedure.
In giving informed consent, subjects may not waive or appear to waive
any of their legal rights, or release or appear to release the investigator,
the sponsor, and the institution or agents thereof from liability
for negligence.
Institution (1):
Any public or private entity or agency (including federal, state,
and local agencies).
Institution (2):
A residential facility that provides food, shelter, and professional
services (including treatment, skilled nursing, intermediate or long-term
care, and custodial or residential care). Examples include general,
mental, or chronic disease hospitals; inpatient community mental
health centers; nursing homes; alcohol and drug addiction treatment
centers; residential schools for the mentally or physically handicapped;
and homes for dependent and neglected children.
Institutional Official:
The individual who signs and has the authority to sign the institution's
Assurances, making a commitment on behalf of the institution that
federal regulations and policies will be followed. The Institutional
Official at UC Berkeley is the Vice Chancellor for Research.
Institutional Review Board:
A committee charged with reviewing and approving the use of human
subjects in all research projects to ensure that the safety and welfare
of subjects are protected. The IRB serves as an institutional compliance
committee and is responsible for reviewing reported instances of
regulatory noncompliance related to the use of human subjects in
research. At UC Berkeley, the IRB is called Committee for Protection
of Human Subjects (CPHS).
Institutionalized:
Confined, either voluntarily or involuntarily (e.g., a hospital,
prison or nursing home).
Interaction:
Any form of communication or interpersonal contact between an investigator
and a human subject.
Inter Institutional Agreement:
An agreement that permits an institution with a Federalwide Assurance
(FWA) to rely on the IRB
review of another institution with an FWA. Also referred to as an
IIA. (See also: Memorandum of Understanding)
Internal Adverse Event:
From the perspective of a UCB Investigator engaged in a multi-center
clinical trial, internal adverse events are those adverse
events experienced by subjects enrolled by the UCB Investigator(s)
(under UCB IRB authority). In the context of a single-site study,
all adverse events would be considered internal adverse events.
Intervention:
Physical procedures by which data are gathered and manipulations
of the individual or the individual’s environment that are
performed for research purposes, including using individuals to evaluate
or test devised products or materials developed through research.
Investigator:
Any individual who contributes in a substantive way to the design,
conduct, and/or analysis of the data of a study at or on behalf of
UC Berkeley.
IO:
See: Institutional Official.
IRB:
See: Institutional Review Board.
Justice:
An ethical principle discussed in the Belmont Report requiring fairness in distribution of burdens and benefits; often
expressed in terms of treating persons of similar circumstances or
characteristics similarly.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | | V - Z
Key Personnel:
The individuals with a significant role in the conduct of the research
(e.g., principal investigator, study coordinator, research associate).
Laser Safety Program:
This program is intended to provide UC Berkeley staff, researchers,
students and visitors with a safe laser use environment. All Class
3 and 4 lasers on the campus must be registered with the UC
Berkeley Non-Ionizing Radiation Safety Program. The Office of Environment,
Health & Safety administers this program for the UC Berkeley
Non-Ionizing Radiation Safety Committee (NIRSC). For more information,
visit Laser Safety on the EH&S website.
Legally Authorized Representative:
A person authorized either by statute or by court appointment to
make legal decisions on behalf of another person. In human subjects
research, an individual or judicial or other body authorized under
applicable law to consent on behalf of a prospective subject to the
subject's participation in the procedure(s) involved in the research.
Limited Data Set:
Protected Health Information that excludes the 16 categories of direct identifiers outlined by HIPAA and may be used or disclosed,
for purposes of research, public health, or health care operations,
without obtaining either an individual's Authorization or a waiver
or an alteration of Authorization for its use and disclosure, with
a data use agreement. The 16 identifiers are:
- Names;
- Postal address information , other than town or city, state, and zip code;
- Telephone numbers;
- Fax numbers;
- Electronic mail addresses;
- Social security numbers;
- Medical record numbers;
- Health plan beneficiary numbers;
- Account numbers;
- Certificate / license numbers;
- Vehicle identifiers and serial numbers (including license plate numbers);
- Device identifiers and serial numbers;
- Web universal Resource Locators (URLs);
- Internet Protocol (IP) address numbers;
- Biometric identifiers, including finger and voice prints; and
- Full-face photographic images and any comparable images.
LUR
:
Laser Use Registration -All Class 3and
4 lasers on the Berkeley campus are required to be operated
under a campus Laser Use Registration (LUR). Use of a Class 3 or
4 laser or laser system without an approved LUR is a violation
of campus safety policy. (See also: Laser Safety Program)
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Mature Minor:
Someone who has not reached adulthood (as deemed by state law) but
who may be treated as an adult for certain purposes (e.g., consenting
to medical care) as permitted by California State Law. Note that
a mature minor is not necessarily an emancipated minor. (See also:
Emancipated Minor)
Medical Device:
An instrument, apparatus, implement, machine, contrivance, implant,
in vitro reagent, or other similar or related article, including
a component part, or accessory which is:
- Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them;
- Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in human or other animals; or
- Intended to affect the structure or any function of the body of human or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of human or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.
Medical Experimentation:
Medical Experimentation is defined by the State of California as:
- the severance or penetration or damaging of tissues of a human subject or the use of a drug or device, electromagnetic radiation, heat or cold, or a biological substance or organism, in or upon a human subject in the practice or research of medicine in a manner not reasonably related to maintaining or improving the health of the subject or otherwise directly benefiting the subject;
- the use of an investigational drug or device; or
- The withholding medical treatment from a human subject for any purpose other than maintenance or improvement of the health of the subject.
Memorandum of Understanding:
An agreement between UC campuses and UC managed laboratories that
will, under certain conditions, allow research to be reviewed by
the IRB at only one location
rather than having to go through the entire IRB review process at
every campus engaged in the research. (See also: Inter Institutional Agreement)
Mentally Disabled:
See: Cognitively Impaired.
Minimal Risk (1):
For non-prisoner studies: the probability and magnitude of harm or
discomfort anticipated in the proposed research are not greater,
in and of themselves, than those ordinarily encountered in daily
life or during the performance of routine physical or psychological
examinations or tests. For example, the risk of drawing a small amount
of blood from a healthy individual for research purposes is no greater
than the risk of doing so as part of routine physical examination.
The definition of minimal risk for research involving prisoners differs
somewhat from that given for non-institutionalized adults.
Minimal Risk (2):
For studies involving prisoner(s): The probability and magnitude
of physical or psychological harm that is normally encountered in
the daily lives, or in the routine medical, dental, or psychological
examination of healthy persons.
Minor Amendment:
Minor changes are defined as changes that, if considered independently
from the overall research, involve no significant alteration in research
design or fall into one or more categories allowing exempt or expedited
review, and involve no more than minimal risk to participants.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
NASA:
National Aeronautics and Space Administration - NASA is
a leading force in scientific research and in stimulating public
interest in aerospace exploration, as well as science and technology
in general.
National Commission:
National Commission for the Protection of Human Subjects of Biomedical
and Behavioral Research. An interdisciplinary advisory body, established
by Congressional legislation in 1974, which was in existence until
1978, and which issued a series of reports and recommendations on
ethical issues in research and medicine, many of which are now embodied
in federal regulations.
NCI
:
National Cancer Institute (NIH) - An institute within NIH.
The National Cancer Institute's goal is to stimulate and support
scientific discovery and its application to achieve a future when
all cancers are uncommon and easily treated.
NCURA
:
National Council of University Research Administrators -
An organization of individuals involved in the administration of
sponsored programs at colleges, universities, and teaching hospitals.
NEI
:
National Eye Institute (NIH) - An institute within NIH.
The National Eye Institute (NEI) conducts and supports research that
helps prevent and treat eye diseases and other disorders of vision.
This research leads to sight-saving treatments, reduces visual impairment
and blindness, and improves the quality of life for people of all
ages.
Neonate:
A new born.
NHGRI
:
National Human Genome Research Center (NIH) – An institute
within NIH. The National Human Genome Research Institute supports
genetic and genomic research, investigation into the ethical, legal
and social implications surrounding genetics research, and educational
outreach activities.
NHLBI
:
National Heart, Lung, and Blood Institute (NIH) - An institute
within NIH. The National Heart, Lung, and Blood Institute (NHLBI)
provides leadership for a national program in diseases of the heart,
blood vessels, lung, and blood; blood resources; and sleep disorders.
Since October 1997, the NHLBI has also had administrative responsibility
for the NIH Woman's Health Initiative.
NIA
:
National Institute on Aging (NIH)- An institute in NIH.
The National Institute on Aging (NIA) leads a broad scientific
effort to understand the nature of aging and to extend the
healthy, active years of life.
NIEHS:
National Institute of Environmental Health Sciences (NIH) - An institute within NIH. The mission of the National Institute
of Environmental Health Sciences (NIEHS) is to reduce the burden
of human illness and dysfunction from environmental causes by understanding
each of these elements and how they interrelate.
NIH:
National Institutes of Health - A groups of federal agencies
within the Public Health Service, DHHS, comprising 21 institutes
and centers. These entities are responsible for carrying out and
supporting biomedical and behavioral research.
NIMH
:
National Institute of Mental Health (NIH) - An institute
within NIH. The mission of the National Institute of Mental Health
(NIMH) is to diminish the burden of mental illness through research.
NIRSC
:
Non-Ionizing Radiation Safety Committee – A body that
sets UCB laser safety policy and is responsible for laser safety
policy development and enforcement. They are directly accountable
to the Provost for Research and their main function is to resolve
safety concerns associated with laser use or with this manual. The
NIRSC is responsible for oversight of the program and coordinating
with the Laser Safety Officer to assure compliance with CCR, Title
8. (See also: Laser Safety Program)
Nonaffiliated Member:
Member of an Institutional Review Board who has no ties to the parent institution, its staff, or faculty.
This individual is usually from the local community (e.g., minister,
business person, attorney, teacher, homemaker).
Noncompliance:
Failure to adhere to regulations, policies, procedures or special
conditions related to the conduct of research. Examples of such noncompliance
include, but are not limited to, failure to obtain/maintain approval
for research; coercion of human subjects; performing unapproved procedures;
and conducting research at unapproved sites. (See also: Simple (Minor) Noncompliance and Serious Noncompliance)
Nonsignificant Risk Device:
An investigational medical device that does not present significant
risk to the patient. (See also: Significant Risk Device)
Nonviable Neonate:
An expelled or delivered fetus which, although it is living, cannot
possibly survive to the point of sustaining life independently, even
with the support of available medical therapy [45 CFR 46.203 (d)
and (e)]. Although it may be presumed that an expelled or delivered
fetus is nonviable at a gestational age less than 20 weeks and weight
less than 500 grams [Federal Register 40 (August 8, 1975): 33552],
a specific determination as to viability must be made by a physician
in each instance. (See also: Viable Infant)
NSF:
National Science Foundation - The National Science Foundation
(NSF) is an independent agency of the U.S. Government. Their mission
is to promote the progress of science; to advance the national health,
prosperity, and welfare; and to secure the national defense.
Nuremberg Code:
A code of research ethics developed during the trials of Nazi war
criminals following World War II and widely adopted as a standard
during the 1950s and 1960s for protecting human subjects.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Office for Protection of Human Subjects:
Office for Protection of Humans Subjects (OPHS) is a division of
the Office of Research Administration and Compliance. The OPHS staff
provide administrative support to UC Berkeley’s Committee for
Protection of Human Subjects (CPHS) and serve as a liaison between
the committee, and the research community as well as other administrative
units. For more information, visit the CPHS/OPHS website.
Off-Label use:
When physicians use a drugs, biologics and devices for a condition
not approved by FDA labeling. Physicians using good medical practice
and the best interests of the patient may use legally available products
for treatment (i.e., non-research purposes) using their best knowledge
and judgment.
OHRP
:
Office for Human Research Protection (formerly known as OPRR
- Office for Protection from Research Risks) - An office within the Department of Health and Human Services
responsible for implementing DHHS regulations (45 CFR Part 46) governing
research involving human subjects.
ONR
:
Office of Naval Research - The Office of Naval Research
(ONR) sponsors science and technology in support of the U.S. Navy
and Marine Corps. Founded in 1946, ONR today funds work at more than
450 universities, laboratories, and other organizations.
OPHS:
See: Office for Protection of Human Subjects.
OPRR:
Office for Protection from Research Risks (DHHS) - See:
Office for Human Research Protections (OHRP).
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Parent:
A child’s biological or adoptive parent.
Parent Permission:
The agreement of parent(s) or guardian to the participation of their
child or ward in research.
Personal Identifiers under HIPAA:
List of 18 Identifiers
- Names.
- All geographic subdivisions smaller than a state, including street address, city, county, precinct, ZIP Code, and their equivalent geographical codes, except for the initial three digits of a ZIP Code if, according to the current publicly available data from the Bureau of the Census:
- The geographic unit formed by combining all ZIP Codes with the same three initial digits contains more than 20,000 people.
- The initial three digits of a ZIP Code for all such geographic units containing 20,000 or fewer people are changed to 000.
- All elements of dates (except year) for dates directly related to an individual, including birth date, admission date, discharge date, date of death; and all ages over 89 and all elements of dates (including year) indicative of such age, except that such ages and elements may be aggregated into a single category of age 90 or older.
- Telephone numbers.
- Facsimile numbers.
- Electronic mail addresses.
- Social security numbers.
- Medical record numbers.
- Health plan beneficiary numbers.
- Account numbers.
- Certificate/license numbers.
- Vehicle identifiers and serial numbers, including license plate numbers.
- Device identifiers and serial numbers.
- Web universal resource locators (URLs).
- Internet protocol (IP) address numbers.
- Biometric identifiers, including fingerprints and voiceprints.
- Full-face photographic images and any comparable images.
- Any other unique identifying number, characteristic, or code, unless otherwise permitted by the Privacy Rule for re-identification.
There are also additional standards and criteria to protect individual's privacy from re-identification. Any code used to replace the identifiers in datasets cannot be derived from any information related to the individual and the master codes, nor can the method to derive the codes be disclosed. For example, a subject's initials cannot be used to code their data because the initials are derived from their name. Additionally, the researcher must not have actual knowledge that the research subject could be re-identified from the remaining identifiers in the PHI used in the research study. In other words, the information would still be considered identifiable is there was a way to identify the individual even though all of the 18 identifiers were removed.
Phase 1, 2, 3, 4 Drug Trials:
Different stages of testing drugs in humans, from first application
in humans (Phase 1) through limited (Phase 2) and broad clinical
tests (Phase 3), to post marketing studies (Phase 4).
PHI:
See: Protected Health Information.
PI:
See: Principal Investigator.
Postdoctoral Investigator:
A postdoctoral scholar with a UCB appointment who conducts research. Student/Postdoctoral
investigators are not considered by CPHS to be principal investigator (PI) on any research project unless granted exceptional PI status.
Postdoctoral scholars who wish to perform human research at
UCB and do not have exceptional PI status must obtain the
sponsorship of a faculty member with PI status.
A postdoctoral investigator has primary responsibility for the design, execution, and management of his or her research project and is involved in the project in a significant manner. S/he is also responsible for the protection of the rights and welfare of the human subjects and adherence by all study personnel to CPHS requirements as well as applicable federal regulations, and state statutes. Note: If a postdoctoral scholar is doing work that is funded by grant on which a faculty member is PI, the faculty member must be listed on the CPHS application as Principal Investigator and the student should be listed as co-investigator or study personnel.
Practicable:
Capable of being done of being done, effected, or put into practice
with the available means; feasible.
Preclinical Investigations:
Laboratory and animal studies designed to test the mechanisms, safety,
and efficacy of an intervention prior to its applications to humans.
Pregnancy:
The period of time from implantation of a fertilized egg within the
uterus until the fetus has entirely left the uterus (i.e., has been
delivered). A woman shall be assumed to be pregnant if she exhibits
any presumptive sign of pregnancy such as missed menses or a positive
pregnancy test. This “assumption” may be in error, but,
for research purposes, investigators would presume that a living
fetus was present until there is clear evidence to the contrary.
Pregnant Woman:
A woman who is in a state of pregnancy. (See also: Pregnancy)
Premarket Approval:
Process of scientific and regulatory review by the FDA to ensure
the safety and effectiveness of Class III devices.
President’s Commission:
President’s Commission for the Study of Ethical Problems in
Medicine and Biomedical and Behavioral Research. An interdisciplinary
advisory group, established by congressional legislation in 1978,
which was in existence until 1983, and which issued reports on ethical
problems in health care and in research involving human subjects.
Principal Investigator:
An employee of UC Berkeley (usually with an academic appointment)
who is eligible under University policy
to submit proposals for extramural support of a research,
training, or public service project, and to perform research
involving human subjects. A PI has primary responsibility
for the design, execution, and management of a research project
and is involved in the project in a significant manner. The PI
is also responsible for the protection of the rights and welfare
of the human subjects and adherence by all study personnel to
CPHS requirements as well as applicable federal regulations, and
state statutes.
As a general rule, the PI on the grant funding the research must be listed as the PI on the CPHS application. All academic senate faculty members, and a few other categories listed in the policy, have PI status by title (i.e. as part of their appointment). Those who do not have PI status by title can request status by exception through the office of the Vice Chancellor for Research.
Prisoner:
An individual involuntarily confined or detained in a penal institution.
The term is intended to encompass individuals sentenced to such an
institution under a criminal or civil statute, individuals detained
in other facilities by virtue of statutes or commitment procedures
which provide alternatives to criminal prosecution or incarceration
in a penal institution, and individuals detained pending arraignment,
trial, or sentencing.
Privacy:
Control over the extent, timing, and circumstances of sharing oneself
(physically, behaviorally, or intellectually) with others.
Private Information:
Information about behavior that occurs in a context in which an individual
can reasonably expect that no observation or recording is taking
place, as well as information which has been provided for specific
purposes by an individual and which the individual can reasonably
expect will not be made public (e.g., private conversation).
Prohibited Conduct:
See part B of the UCOP Policy on Sexual Harassment and Sexual Violence.
Protected Health Information:
Individually identifiable health information (refer to: Personal Identifiers under HIPAA); transmitted or maintained in any form or medium (electronic,
oral or paper) by a covered entity or its business associates.
(See also: Health information and Individually identifiable health
information)
Protocol:
The formal design or plan of an experiment or research activity;
specifically, the plan submitted to an IRB for review and to an agency for research support. The protocol
includes a description of the research design or methodology to be
employed, the eligibility requirements for prospective subjects and
controls, the treatment regimen(s), and the proposed methods of analysis
that will be performed on the collected data.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Recruitment Registry:
An organization that collects and maintains contact information from
individuals who have agreed to join an established subject pool in
order to receive information about available research.
Recruitment Database:
An organization that collects and maintains contact information,
as well as health, demographic, and/or screening data, from individuals
who have agreed to join an established subject pool in order to receive
information about available research. The subject pool data may also
be used to determine eligibility for future invitation to participate
in research and included in the evaluation of study outcomes.
Radiation Safety Committee:
A body of faculty and other radiation experts appointed by the Vice
Chancellor for Research (VCR) to establish policies and procedures
for the use of ionizing radiation at UC Berkeley. In addition, the
Radiation Safety Committee (RSC) maintains surveillance over the
program and provides periodic program status reports to the VCR.
Surveillance activities include the review and approval of radiation-use
applications and the review of Environment, Health & Safety radiation
safety and radioactive waste related operations. (See also: RUA - Radiation Use Authorization) For more information, visit Radiation Safety on the EH&S website.
Regs:
Short for “regulations.”
Regulations:
The contractual rules and procedures governing sponsored research
projects.
Related:
An event is considered related if it is at least possibly related to the research (i.e., there is a reasonable possibility that the incident, experience
or problem may have been caused by the procedures involved in the
research).
Probably related – An event that in the judgment of the researcher is likely caused by the research activities or likely affected the rights and welfare of the participants. The event has a timely relationship to the research and follows a known pattern of response, but a potential alternative cause may be present.
Possibly related – An event that in the judgment of the researcher is possibly caused by the research activities or that possibly affected the rights and welfare of the participants. The event has a timely relationship to the research; however no known pattern of response exists, and an alternative cause may be more likely, but a possible relationship to research activities cannot reasonably be ruled out.
Unrelated– An event that in the judgment of the researcher is known and is in no way related to any aspect of the research activities or in no way affected the rights and welfare of the participants.
Renewal:
See: Continuing Review.
Research:
A systematic investigation, including research development, testing
and evaluation, designed to contribute to generalizable knowledge.
(See also: Human Subject)
Research Health Information:
The University of California employs the term “Research Related
Health Information” (RHI) to identify types of data used in
research that would be personally identifiable but not considered
Protected Health Information (PHI) under the HIPAA “Privacy Rule.”
RHI shares some characteristics with HIPAA PHI, but the key distinction
between RHI and PHI is that PHI is associated with or derived from
a healthcare service event, i.e., the provision of care or payment
for care. RHI is not associated or derived from the provision of
care or payment for care.
Respect for Persons:
An ethical principle discussed in the Belmont Report requiring that individual autonomy be respected and that persons
with diminished autonomy be protected.
Responsible Employee:
Any
University employee who is not a Confidential Resource and who receives, in the course of employment, information that
a student (undergraduate, graduate, or professional) has suffered
sexual violence, sexual harassment or other prohibited behavior shall
promptly notify the Title IX Officer or designee. This includes Resident
Assistants, Graduate Teaching Assistants, and all other student employees,
when disclosures are made to any of them in their capacities as employees.
In addition, the following who, in the course of employment, receive a report of Prohibited Conduct from any other person affiliated with the University shall notify the Title IX Officer or designee:
- Campus Police
- Human Resource Administrators, Academic Personnel, and Title IX Professionals
- Managers and Supervisors including Deans, Department Chairs, and Directors of Organized Research Units (ORU)
- Faculty members
RHI:
See: Research Health Information.
Risk:
The probability of harm or injury (physical, psychological, social,
or economic) occurring as a result of participation in a research
study. Both magnitude of possible harm may vary from minimal to significant.
(See also: Minimal Risk)
Risk/Benefit ratio:
The risk to a participant versus the potential benefits; the risk/benefit
ratio differs depending on the nature of the research. The principle
of beneficence requires a systematic assessment of all possible harms,
including physical, psychological, social, and economic. The principle
of beneficence requires both protecting participants against risk
of harm and consideration of not only the benefits for the participant,
but also the societal benefits that might be gained from the research.
RUA
:
Radiation Use Authorization – A written authorization for specific
uses of radiation and radioactive material granted by the Radiation
Safety Officer (RSO) and/or Radiation Safety Committee (RSC) to the Radiation Use Authorization (RUA) holder. An approved
RUA is required before purchasing or using any source of ionizing
radiation at UC Berkeley.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Screening:
The process of finding out, whether the subject is suitable for the
study in question. It is based on exclusion criteria defined in the
study protocol, such as age, current state of health and medication,
medical history, etc. Before screening procedures, the subject is
required to give his/her written informed consent to participate
in the study.
SCRO:
See: Stem Cell Research Oversight Committee.
Secretary:
A U.S. Cabinet Officer. In the context of DHHS-conducted or -supported
research, usually refers to the Secretary of Health and Human Services.
Serious Adverse Event:
Any adverse event temporally associated with the subject’s
participation in research that meets any of the following criteria:
- results in death;
- is life-threatening (places the subject at immediate risk of death from the event as it occurs);
- requires inpatient hospitalization or prolongation of existing hospitalization;
- results in a persistent or significant disability/incapacity;
- results in a congenital anomaly/birth defect; or
- any other adverse event that, based upon appropriate medical judgment, may jeopardize the subject’s health and may require medical or surgical intervention to prevent one of the other outcomes listed in this definition (Examples include allergic bronchospasm requiring intensive treatment in the emergency room or at home, blood dyscrasias or convulsions that do not result in inpatient hospitalization, or the development of drug dependency or drug abuse).
Serious Noncompliance:
Noncompliance that adversely affects the rights or welfare of participants.
Significant Risk Device:
An investigational device that:
- Is intended as an implant and presents a potential for serious risk to the health, safety, or welfare of a subject;
- Is purported or represented to be for use in supporting or sustaining human life and presents a potential for serious risk to the health, safety, or welfare of a subject;
- Is for a use of substantial importance in diagnosing, curing, mitigating, or treating disease, or otherwise preventing impairment of human health and presents a potential for serious risk to the health, safety, or welfare of a subject; or
- Otherwise presents a potential for serious risk to the health, safety, or welfare of a subject.
Note: An IDE application must be submitted to the FDA if the device involved in the research is determined to be significant risk.
Simple (Minor) Noncompliance:
Failure to comply with the requirements of an applicable law, regulation,
or institutional policy pertaining to the protection of human subjects,
and/or with the requirements or determinations of an IRB.
SPO:
See: Sponsored Projects Office.
Sponsor:
For FDA-regulated research: The entity who initiates, but who does
not actually conduct, the research (e.g., a pharmaceutical company).
The sponsor may or may not also be the entity that is funding the
research.
For non-FDA-regulated research: The entity who funds the research.
Also referred to as the “funder.”
Sponsor-Investigator:
An individual who both initiates and actually conducts the research.
A sponsor-investigator must meet the requirements and obligations
of both the investigator and the sponsor described in FDA regulations.
Sponsored Projects Office:
The Sponsored Projects Office (SPO) is a division of the Office of
Research Administration and Compliance. SPO staff is responsible
for reviewing and submitting contract and grant proposals, accepting
grants, and negotiating contracts for extramurally-funded research,
training, and public service projects. SPO staff act as UCB’s
institutional official in matters involving the sponsor’s awarding
office. SPO is also responsible for post-award activities, such as
approving certain actions delegated to the campus by sponsors, obtaining
sponsor approvals as required, resolving problems that arise during
the project period, reviewing consultant agreements, and assuring
compliance with University and sponsor policies and regulations.
For more information, visit the SPO website.
Stem Cell Research Oversight Committee:
The Stem Cell Research Oversight (SCRO) Committee is a campus committee
appointed by the Vice Chancellor for Research and charged with ensuring
that research involving the derivation or use of human stem cells
at the University of California, Berkeley is conducted with the highest
ethical and scientific research standards, and in compliance with
all applicable federal and state regulations, University policies,
and the requirements of extramural research sponsors. For more information,
visit Stem Cell Research Oversite on the RAC website.
Student Investigator:
An undergraduate or graduate student enrolled at UCB who conducts
research with human subjects. Student investigators are not considered by CPHS to be principal investigator (PI) on any research project. Students who wish to perform human research at UCB must
obtain the sponsorship of a faculty member with PI status. A Student Investigator has primary responsibility for the design,
execution, and management of his or her research project and is involved
in the project in a significant manner. S/he is also responsible
for the protection of the rights and welfare of the human subjects
and adherence by all study personnel to CPHS requirements as well
as applicable federal regulations, and state statutes. Note: If a student is doing work that is funded by grant on
which a faculty member is PI, the faculty member must be
listed on the CPHS application as Principal Investigator and
the student should be listed as study personnel.
Student Subject Pool:
A subject pool that is typically comprised of undergraduate students
enrolled in particular courses requiring, as part of the curriculum,
research experience either
through participation in one or more research projects, or an alternative
assignment in lieu of participation in research.
Subject Pool:
An aggregation of people from which research participants may be
recruited. (See also: Student Subject Pool)
Surrogate Consent:
Consent obtained from a legally authorized representative on behalf
of a participant determined to lack decision-making capacity. AB
2328, codified as California Health & Safety Code Section 24178
and effective January 1, 2003, clarifies who may serve as a research
subject’s “legally authorized representative”,
referenced in 45 CFR 46 and therefore authorized under those federal
regulations to provide surrogate consent for the potential research
subject to participate in research.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
Therapeutic Misconception:
Research participant's belief that enrolling in a research study
will provide therapeutic benefit. Participants confuse the goal of
clinical therapy which is to provide benefit to the individual patient
and where any new knowledge gained is incidental and the goal of
research which is to gain knowledge to help future patients (generalizable)
and where therapeutic benefit to individual maybe secondary.
UCOP:
University of California Office of the President.
Unanticipated:
An event is when “unanticipated” when it was unforeseeable
at the time of its occurrence. Unanticipated and unexpected are not
synonymous. A research protocol can monitor for an unexpected event,
but cannot monitor for an unforeseen event. All unanticipated events
are unexpected but not vice versa.
Unanticipated Problems Involving Risk to Participants or
Others:
An incident, experience, or outcome that meets all of the
following criteria:
- unexpected (in terms of nature, severity or frequency) given (a) the research procedures that are described in the protocol-related documents, such as the IRB-approved research protocol and informed consent document; and (b) the characteristics of the subject population being studied;
- related or possibly related to participation in the research (possibly related means there is a reasonable possibility that the incident, experience, or outcome may have been caused by the procedures involved in the research); and
- suggests that the research places subjects or others at a greater risk of harm (including physical, psychological, economic, or social harm) than was previously known or recognized.
Undue Influence:
Improper influence that deprives a person of freedom of choice or
substitutes another’s choice or desire for the person’s
own.
Unexpected:
An event is unexpected when its specificity and severity are not
accurately reflected in the informed consent document.
Unexpected Adverse Event:
Any adverse event occurring in one or more subjects in a research
protocol, the nature, severity, or frequency of which is not consistent with either:
- the known or foreseeable risk of adverse events associated with the procedures involved in the research that are described in (a) the IRB-approved documents (e.g., applicable investigator brochure, current protocol narrative, current informed consent document), and (b) other relevant sources of information, such as product labeling and package inserts; or
- the expected natural progression of any underlying disease, disorder, or condition of the subject(s) experiencing the adverse event and the subject’s predisposing risk factor profile for the adverse event.
A | B | C | D | E | F | G - H | I - J | K - L | M | N | O | P - Q | R | S | T - U | V - Z
VA:
Veterans Affairs - The Department of Veterans Affairs (VA)
was established on March 15, 1989. It succeeded the Veterans Administration
and has responsibility for providing federal benefits to veterans
and their dependents. Headed by the Secretary of Veterans Affairs,
VA is the second largest of the 14 Cabinet departments and operates
nationwide programs of health care, financial assistance and national
cemeteries.
VCR:
Vice Chancellor for Research - The Institutional Official (IO) for human research at UC Berkeley.
Viable Infant:
When referring to a delivered or expelled fetus, the term “viable
infant” means likely to survive to the point of sustaining
life independently, given the benefit of available medical therapy
[45 CFR 46.203(d)]. This judgment is made by a physician. In accordance
with DHHS regulations, the Secretary, HHS, may publish guidelines
to assist in the determination of viability. Such guidelines were
published in 1975, and specify an estimated gestational age of 20
weeks or more and a body weight of 500 grams or more as indices of
fetal viability [Federal Register 40 (August 8, 1975): 33552]. These
indices depend on the state of present technology and may be revised
periodically. (See also: Nonviable Neonate)
Voluntary:
Free of coercion, duress, or undue inducement. Used in the research
context to refer to a subject’s decision to participate (or
to continue to participate) in a research activity.
Volunteer Research Assistant:
An individual who will assist with research activities and meets
the following criteria:
- is not acting as an employee or agent of another institution or organization;
- has no intention of obtaining and/or using the data from the research project for their own research; and
- is not receiving remuneration for services rendered.
An example of a volunteer research assistant is a recent college graduate volunteering for laboratory experience before applying to graduate school. An example of someone who does not qualify to be a volunteer research assistant is a visiting researcher who is receiving a stipend from his/her home institution or government while at UC Berkeley.
Vulnerable Subject:
Human subjects/participants who are likely to be vulnerable to coercion
or undue influence (e.g., students, subordinates, patients). Also,
individuals who cannot give informed consent because of limited autonomy
(e.g., children, mentally ill, prisoners).